Overview

Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients

Status:
Completed
Trial end date:
2017-01-23
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetic and safety for the esomeprazole use for schizophrenia
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
National Taiwan University
Treatments:
Esomeprazole